|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.401
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.318
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.267
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.257
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.222
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.201
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.200
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.189
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.183
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.183
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.177
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.174
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.171
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.160
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.154
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.153
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.148
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.147
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.145
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.133
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.130
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.128
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.125
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.122
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.122
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.121
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.118
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.117
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.117
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.113
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.106
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.106
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.101
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.096
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.095
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.094
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.092
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.091
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.090
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.089
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.089
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.088
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.085
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.084
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.084
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.083
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.083
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.083
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.083
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.082
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.082
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.081
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.080
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.079
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.079
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.077
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.075
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.074
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.073
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.073
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.073
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.072
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.072
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.071
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.070
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.070
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.070
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.069
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.068
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.067
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.067
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.066
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.063
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.063
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.062
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.062
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.062
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.062
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.061
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.058
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.057
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.056
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.056
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.056
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.055
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.055
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.054
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.053
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.053
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.053
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.053
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.053
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.052
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.052
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.052
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.052
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.052
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.052
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.051
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.050
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.049
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.049
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.049
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.049
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.049
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.048
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.048
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.047
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.047
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.047
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.047
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.046
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.046
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.046
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.045
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.045
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.045
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.045
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.045
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.045
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.045
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.044
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.044
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.044
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.044
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.044
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.044
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.043
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.043
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.043
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.042
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.042
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.042
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.042
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.042
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.042
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.042
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.042
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.042
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.041
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.041
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.041
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.040
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.040
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.040
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.040
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.040
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.040
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.040
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.039
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.039
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.039
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.039
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.039
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.038
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.038
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.038
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.038
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.037
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.037
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.037
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.037
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.037
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.037
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.037
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.037
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.036
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.036
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.036
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.036
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.036
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.036
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.036
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.035
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.035
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.035
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.035
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.035
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.034
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.034
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.034
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.034
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.034
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.034
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.034
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.034
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.034
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.034
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.033
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.033
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.033
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.033
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.032
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.032
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.032
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.032
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.032
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.031
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.031
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.031
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.031
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.031
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.031
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.031
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.031
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.031
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.030
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.030
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.030
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.030
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.030
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.030
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.029
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.029
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.029
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.029
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.029
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.029
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.029
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.029
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.029
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.029
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.029
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.028
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.028
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.028
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.028
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.027
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.027
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.027
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.027
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.027
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.027
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.027
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.027
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.027
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.027
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.027
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.027
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.027
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.026
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.026
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.026
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.026
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.026
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.026
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.026
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.026
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.026
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.026
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.025
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.025
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.025
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.025
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.025
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.025
|
|
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.025
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.025
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.025
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.025
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.025
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.025
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.025
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.025
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.024
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.024
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.024
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.024
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.024
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.024
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.024
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.024
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.024
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.024
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.024
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.023
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.023
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.023
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.023
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.023
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.023
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.023
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.022
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.022
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.022
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.022
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.022
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.022
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.022
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.022
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.022
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.022
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.021
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.021
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.021
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.021
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.021
|
|
|
|
regulation of t cell apoptotic process
|
GO:0070232 |
28 |
0.021
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.021
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.021
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.021
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.021
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.021
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.021
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.021
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.021
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.020
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.020
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.020
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.020
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.020
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.020
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.020
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.020
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.020
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.020
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.020
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.020
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.020
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.020
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.020
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.020
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.020
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.019
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.019
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.019
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.019
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.019
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.019
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.019
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.019
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.019
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.019
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.019
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
t cell costimulation
|
GO:0031295 |
14 |
0.019
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.019
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.018
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.018
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.018
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.018
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.018
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.018
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.018
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.018
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.018
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.018
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.018
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.018
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.018
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.018
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.018
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.017
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.017
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.017
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.017
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.017
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.017
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.017
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.017
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.017
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.017
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.017
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.017
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.017
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.016
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.016
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.016
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.016
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.016
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.016
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.016
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.016
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.016
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.016
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.016
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.016
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.016
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.016
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.016
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.016
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.016
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.016
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.016
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.016
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.016
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.016
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.015
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.015
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.015
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.015
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.015
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.015
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.015
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.015
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.015
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.015
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.015
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.015
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.015
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.015
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.015
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.015
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.015
|
|
